The Future of Pharma in Space

At this stop on Pharma's Almanac's Road to 50 States trans-American road trip, Bill Goodman, CEO and President at Goodman Technologies LLC, talks to Nigel about the future of pharma in space and how he sees it being activated over the next decade.

Nice Insight

Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.

Goodman Technologies

Goodman Technologies LLC (GT) is a Small Business that performs Professional, Scientific, System Engineering, and Technical Services. GT provides Leading Edge and Value Added Solutions and C-Level Results Coaching that allows our customers to achieve their next Breakthrough! Our Multi-Disciplinary team of Subject Matter Experts (SMEs) from Industry and Academia uses a “Systems Engineering Point-of-View™” to arrive at Solutions that Manage, Mitigate and Balance Budgetary, Schedule and Technical Risks. GT’s Global Vendor Network which includes 3D and Additive Manufacturing in Polymers, Ceramics, Metals and Composites provides a Capability to Analyze, Design, Manufacture, Integrate and Test Complex System Level Products. GT’s Patent Pending disruptive nanoceramic materials provide solutions for your high temperature, deep cryogenic temperatures, nuclear and space effects environments challenges. Applications we pursue include Space Structures, Space Optical and Optical/RF Systems, Shielding, Armor and Thermal Protection.

Q: